Results 21 to 30 of about 9,302 (232)
Identification of Adverse Drug Events from the FAERS Database Utilizing the Low-Code KNIME Platform
, 2023 This thesis aims to tackle the challenges of utilizing the FDA Adverse Event Reporting System (FAERS) for extracting and comprehending drug safety data.
Basalelah, Lama
core +1 more source
Analyzing the approach used for cleaning drug names in FAERS database
, 2023 Analyzing the approach used for cleaning drug names in FAERS ...
Saam Gough, Hami Piaa
core +1 more source
List of drugs whose −log P is 308 in the FAERS ALL result.
, 2021 Drugs whose −log P is 308 and lnRORs were greater than 0 in the FAERS ALL result. These drugs are listed in descending order of ROR. (DOCX)
Junko Nagai (11785635) +1 more
core +1 more source
List of drugs whose −log P is 308 in the FAERS CNS result.
, 2021 Drugs whose −log P is 308 and lnRORs were greater than 0 in the FAERS CNS result. These drugs are listed in descending order of ROR. (DOCX)
Junko Nagai (11785635) +1 more
core +1 more source
Interstitial pneumonia signals of apalutamide, darolutamide, and enzalutamide in FAERS and JADER. [PDF]
Front OncolBackground Apalutamide, darolutamide, and enzalutamide are widely used androgen receptor signaling inhibitors (ARSIs) for prostate cancer.
Zheng Z, Zhao Z, Jin P.
europepmc +2 more sources
Top adverse effects for cholinesterase inhibitors in FAERS database.
, 2016 Top adverse effects for cholinesterase inhibitors in FAERS database.
Winston Yuchen Chen (834602) +4 more
core +1 more source
List of drugs whose −log P is 308 in the FAERS PNS result.
, 2021 Drugs whose −log P is 308 and lnRORs were greater than 0 in the FAERS PNS result. These drugs are listed in descending order of ROR. (DOCX)
Junko Nagai (11785635) +1 more
core +1 more source
FAERS database analysis of reported serious adverse effect.
, 2016 FAERS database analysis of reported serious adverse effect.
Winston Yuchen Chen (834602) +4 more
core +1 more source
Endocrine ConnectionsObjective: This study aimed to assess the latent threat of depression and suicide/self-injury associated with the combination of glucagon-like peptide-1 agonists (GLP-1RAs) and metformin versus GLP-1RAs monotherapy, through analyzing the data from the ...
Wenjun Ji +3 more
doaj +1 more source
Frontiers in Pharmacology, 2018 Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequacies of single source. However, analytic methods to monitor potential ADEs after prolonged drug exposure are still lacking.
Liwei Wang +10 more
doaj +1 more source